(Q44158486)

30 November 2017

title

Are early clinical effects of cholesterol lowering mediated through effects on inflammation? (English)

1 reference

30 November 2017

0 references

Olsson AG

1

1 reference

30 November 2017

Schwartz GG

series ordinal

2

1 reference

30 November 2017

Jonasson L

series ordinal

3

1 reference

30 November 2017

Linderfalk C

series ordinal

4

1 reference

30 November 2017

publication date

1 October 2002

1 reference

30 November 2017

1 reference

30 November 2017

volume

176

1 reference

30 November 2017

issue

2

1 reference

30 November 2017

page(s)

147-150

1 reference

An HMG-CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro

30 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-201X.2002.01017.X

Effect of hydroxymethyl glutaryl coenzyme a reductase inhibitor therapy on high sensitive C-reactive protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-201X.2002.01017.X

Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-201X.2002.01017.X

Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events (CARE) Investigators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-201X.2002.01017.X

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-201X.2002.01017.X

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-201X.2002.01017.X

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-201X.2002.01017.X

Immune system activation follows inflammation in unstable angina: pathogenetic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-201X.2002.01017.X

Simvastatin inhibits the monocyte expression of proinflammatory cytokines in patients with hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-201X.2002.01017.X

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-201X.2002.01017.X

10.1046/J.1365-201X.2002.01017.X

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference